Source file signed link, expires in 15 minutes
Extracted text 30
Page 1
DISCLAIMER
Copyright © 2025 Hak Cipta © 2025
by PT Multi Medika Internasional, Tbk oleh PT Multi Medika Internasional, Tbk
All rights reserved. No part of this publication may be Seluruh hak cipta. Tidak ada bagian dari publikasi ini
reproduced and distributed in any form by any means, yang boleh direproduksi dan didistribusikan dalam
electronic or mechanical, including photocopying, bentuk apa pun dengan cara apa pun, elektronik atau
recording, or storage of any information on a retrieval mekanis, termasuk fotokopi, perekaman, atau
system, without the written permission of the publisher penyimpanan informasi apa pun pada sistem
and the copyright owner, except in regarding pengambilan, tanpa izin tertulis dari penerbit dan
educational goals. For further information, please pemilik hak cipta, kecuali dalam mengenai tujuan
contact PT Multi Medika Internasional regarding Public pendidikan. Untuk informasi lebih lanjut silahkan
Expose. menghubungi PT Multi Medika Internasional
mengenai Paparan Publik.
PT MULTI MEDIKA INTERNASIONAL, Tbk
Jl. Peternakan III, no. 55b, Kapuk PT MULTI MEDIKA INTERNASIONAL, Tbk
Jakarta Barat 11720 - INDONESIA Jl. Peternakan III, no. 55b, Kapuk
Jakarta Barat 11720 - INDONESIA
Page 2
PUBLIC EXPOSE
PT Multi Medika Internasional Tbk
Jakarta, 2 Juni 2025
Page 3
Agenda Public Expose Tahun 2025 1. Sekilas Tentang Perseroan 2. Kegiatan Usaha Perseroan 3. Keunggulan Kompetitif dan Strategi Usaha Perseroan 4. Kinerja dan Rasio Keuangan
Page 4
Sekilas Tentang Perseroan Riwayat Singkat Perseroan PT Multi Medika Internasional, Tbk (MMI) perusahaan terbuka yang berfokus dalam pembuatan produk dan distribusi di Indonesia melalui channel Modern Trade dan E-Commerce. PT Multi Medika Internasional Tbk (MMI) memiliki partner retail terbesar di Indonesia yang memiliki ratusan hingga ribuan toko di seluruh Indonesia. MMI juga berkolaborasi secara official dengan Global Intellectual Property sehingga membuat produk yang di kembangkan memiliki nilai tambah dalam meningkatkan benefit dan value dari produk yang dikembangkan
Page 5
VISI, MISI dan NILAI PERUSAHAAN
Vision Mission
Become a distributor and develop innovative
Participate in improving daily
and trusted new products for health and daily
consumer needs.
care in the Indonesian and global markets.
Value
"Achieving Consumer Confidence In Quality & Lifestyle".
We will continue to provide BETTER QUALITY AND LIFESTYLE in personal care, health, and daily
necessities products at the best prices in the market. We emphasize that the products we develop are safe and
quality to increase the confidence of all customers.
Page 6
Milestone
Page 7
Komposisi Saham per 31 Desember 2024
Page 8
Allen Feliciano Togu C. Simanjuntak
Board of Commisioner Komisaris Utama Komisaris Independen
Board of Director
Mengky Mangarek Eveline N Susanto
CEO & FOUNDER CFO
Page 9
Kegiatan Usaha Perseroan
Page 10
Portofolio Produk & Kegiatan Perseroan
1. Own Product with official IP 2. Pop Up Store BTS & TinyTAN 3. Private Label Product Alfamart
Licensed Product
4. Private Label Product Indomaret 5. B2B Licensing Collaboration
And many more..
Page 11
Jaringan dan Distribusi
Page 12
Keunggulan Kompetitif dan Strategi Usaha Rencana Kerja dan Pengembangan Bisnis Perseroan Program kerja dan strategi Perseroan di Tahun 2025 : 1. Penandatanganan Perjanjian Kerjasama antara Perseroan dengan Fujian Nice Paper Hygiene Products, Co., Ltd 2. Perseroan meluncurkan produk Miubaby diapers renceng dan ukuran super jumbo 3. Perseroan berencana mengeluarkan wet tissue dan tissue travel
Page 13
Keunggulan Kompetitif dan Strategi Usaha 1. Penandatanganan Perjanjian Kerjasama antara Perseroan dengan Fujian Nice Paper Hygiene Products, Co., Ltd
Page 14
Keunggulan Kompetitif dan Strategi Usaha 2. Perseroan meluncurkan produk MiuBaby diapers renceng dan ukuran super jumbo
Page 15
Keunggulan Kompetitif dan Strategi Usaha 3. Perseroan berencana mengeluarkan wet tissue dan tissue travel
Page 16
Produk-produk yang telah dikeluarkan Perseroan
Page 17
Kinerja Penjualan (by Customer)
Kinerja Penjualan Q1 2025
SGI
32%
Rp 17.571.758.555 Rp 15.569.715.009 Rp 12.059.027.710
Other
ALFAMIDI
2%
2%
INDOGROSIR
4% INDOMARET
36% OTHERS
ALFAMART
24% Rp 1.811.920.861 Rp 840.325.500 Rp 1.008.138.189
SGI INDOMARET
ALFAMART INDOGROSIR
ALFAMIDI Other
Page 18
Kinerja Penjualan (by Product)
Kinerja Penjualan
(Dalam jutaan Rupiah) ▪ Total Pendapatan bersih Perseroan pada
48,861 Q1 2025 sebesar Rp 48,8milyar,
mengalami kenaikan signifikan sebesar
62,1% dibandingkan dengan total
+62,1% pendapatan pada periode Q1 tahun 2024
yaitu sebesar Rp 30,1milyar.
36,996
▪ Kontribusi penjualan by produk pada Q1
30,151 2025 didominasi dari Masker, Diapers
+83,5%
dan Tissue. Dimana untuk produk
Masker mengalami kenaikan signifikan
yaitu sebesar 83,5%.
20,163
▪ Perseroan terus melakukan inovasi dan
pengembangan produk untuk
memenuhi kebutuhan harian
8,593 pendukung kesehatan dari masyarakat,
6,786
dengan meluncurkan produk Alkali
2,641 Water, dimana di periode Q1 2025 telah
1,861
1,327 613 - 18 14 - mencatatkan pendapatan sebesar Rp
613juta.
Masker Diapers Tissue Alkali Water Merchandise Coffee Total
Q1 2025 Q1 2024
Page 19
Kinerja dan Rasio Keuangan
Kinerja Laba (Rugi)
(Dalam jutaan Rupiah)
Profit Performance YTD Q1 2025 ▪ Pada periode Q1 2025 Perseroan
membukukan Net Profit sebesar Rp
51,649 1,2milyar, mengalami kenaikan
48,861
172,4% dibandingkan dengan
periode Q1 tahun sebelumnya
31,666 dimana membukukan Net Loss
30,150 29,547
sebesar –Rp 1,6milyar
19,967
▪ Gross Profit Perseroan juga
10,900
mengalami kenaikan, pada Q1 2025
1,223 Perseroan membukukan Gross
Profit sebesar Rp 29,5milyar, naik
-1,690 48% dari Gross Profit periode Q1
2024 yang dibukukan sebesar Rp
19,9milyar.
Q1 - 2023 Q1 - 2024 Q1 - 2025
Sales Gross Profit Net Profit
Page 20
Rasio Keuangan
Current Ratio (x) Debt to Asset Ratio (x) Debt to Equity Ratio (x)
2.08 0.6 0.6
1.72 1.73 0.4 1.3 1.2
0.8
31 DEC 2023 31 DEC 2024 31 MAR 2025 31 DEC 2023 31 DEC 2024 31 MAR 2025 31 DEC 2023 31 DEC 2024 31 MAR 2025
▪ Current Ratio Perseroan pada ▪ Debt to Asset Ratio Perseroan ▪ Debt to Equity Ratio pada periode
periode Q1 2025 sebesar 1,73x , pada periode Q1 2025 dan Q4 Q1 2025 sebesar 1,2x , mengalami
mengalami kenaikan 0,01x 2024 relatif stabil yaitu sebesar penurunan 0,1x dibandingkan
dibandingkan dengan Current 0,6x. dengan periode Q4 2024 yaitu
Ratio pada periode Q4 2024 sebesar 1,3x.
sebesar 1,72x. ▪ Perseroan terus berupaya
menjaga stabilitas antara asset ▪ Perseroan secara konsisten terus
▪ Pertumbuhan Current Ratio ini dan liability sehingga dapat berupaya menurunkan rasio Debt
secara umum menggambarkan tercapai tingkat leverage asset to Equity sehingga
kemampuan likuiditas Perseroan dan liability yang optimal. mengoptimalkan tingkat
yang tumbuh dengan baik. leverage antara debt dan equity
Perseroan.
Page 21
Laporan Laba Rugi dan
Rasio Keuangan (2021- Q1 2025)
Dalam Jutaan Rupiah
Page 22
PROYEKSI PENJUALAN
Page 23
BUSINESS PLAN
MMI will develop a new line of products
in personal care such as:
FMCG
Facial Wash, Deodorant, Body Mist, etc. NON
MMI will also be focusing in creating and bringing FOOD OMNI
premium Food and Beverage products for our
customers. CHANNEL
MMI still focus on its core strength, which are
disposable masks and surgical masks in combination
with personal hygiene products, such as wet tissue &
antiseptic products.
MMI believe that entertainment and digital will
always continue to grow. Thus, we will make an
innovation and integrated planning in
Entertainment and Digital.
As an integrated company, we know the FMCG
importance of making our presence known
through online and offline stores to expand our FOOD
reach to more customers.
ENTERTAINMENT
BUSINESS
HEALTH
CARE
Page 24
DIAPERS MANUFACTURING
BENEFITS
Improve domestic Increase Foreign Decrease Import Need and
Create New Jobs
Industry Exchange Cost Saving
UP
200%
HUGE MARKET GOVERNMENT TAX LOCALIZE
OPPORTUNITY ISSUE MANUFACTURING
Page 25
Source: Helix Strategy
MARKET LANDSCAPE
CAGR
The Baby Diapers Market in Indonesia
11%
2023 - 2028 The Indonesian baby diapers market is on a significant growth trajectory, with a
value of USD 2,057 million (IDR 30 Trillion) in 2022 expected to boast an impressive
USD 3,838 million CAGR of 11% from 2023 to 2028. Urbanization plays a pivotal role in this expansion, as
(in 2028) more individuals migrate to cities for career opportunities, leading to higher
disposable income levels and an increased demand for convenient, time-saving
products like disposable diapers.
USD 2,057 million
(in 2022)
WINDOW OF CONSUMPTION
Age & Weight Age & Weight Age & Weight
0-1yo | 7-12kg 1-3yo | 12-18kg 3-5yo | 11-24kg
Diapers Usage Diapers Usage Diapers Usage
8 pcs / day 6 pcs / day 1 pcs / day
2,920 / Years 2,190 / Years 360 / Years
During this 5 years window of consumption, total consumption per user will be 8,020 pcs valued at 16 Mio IDR. Considering 2.141.190
target market universe the potential market size is 34 Trillion IDR.
Page 26
NEW PRODUCT LAUNCH 2025
More Time
TinyTAN
AirPatch Miutiss Gokko
HBPL Wet Wipes
Feb Apr Jun Aug Oct Dec
Jan Mar May Jul Sep Nov
MiuBaby SQ Super pH8+ Miu Comfort Miu Baby Royal
Super Jumbo Coco Melon
& Sachet
Note : NPD Launch
Start Selling
New Contract
Page 27
MIUBABY AWARDED
Awarded 2 MURI Records for Innovation in Diaper Technology and
Recognized with the Top Innovation Choice Award for Pioneering
SAP Paper & SAP Gel Technology in Indonesia.
Page 28
Page 29
TERIMA KASIH
Page 30
SESI TANYA JAWAB
Names mentioned 3 people and organisations named in the text · linked when the evidence is strong
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.